Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
13F holders, Q1 2026
Institutional positions in Cidara Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
CDTX is no longer listed, and 13F filings after Q4 2025 list far fewer holders. See Q4 2025
- Institutional holders
- 0
- −247 vs. Q4 2025
- Shares held
- 0
- −30.6M (−100.0%) vs. Q4 2025
- Total value
- $0
- −$6.76B (−100.0%) vs. Q4 2025
- New holders
- 0
- 0 more added
- Sold out
- 247
- 0 more reduced
8 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 255 | $7.36B |
| Q3 2025 | 173 | $3.11B |
| Q2 2025 | 109 | $1.26B |
| Q1 2025 | 46 | $205.9M |
| Q4 2024 | 40 | $183.6M |
| Q3 2024 | 27 | $35.6M |
| Q2 2024 | 26 | $16.9M |
| Q1 2024 | 50 | $20.3M |
| Q4 2023 | 51 | $18.4M |
| Q3 2023 | 52 | $22.7M |
| Q2 2023 | 52 | $29.7M |
| Q1 2023 | 54 | $34.4M |
| Q4 2022 | 42 | $20.2M |
| Q3 2022 | 42 | $17.1M |
| Q2 2022 | 46 | $13.3M |
| Q1 2022 | 44 | $25.2M |
| Q4 2021 | 53 | $39.5M |
| Q3 2021 | 50 | $42.1M |
| Q2 2021 | 55 | $40.5M |
| Q1 2021 | 62 | $56.6M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Cidara Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −3,365,523−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −1,680,662−100.0% | Sold out |
| HBK Investments L P | 0 | $0 | 0.00% | −1,260,000−100.0% | Sold out |
| FIL Ltd | 0 | $0 | 0.00% | −1,257,574−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,074,924−100.0% | Sold out |
| Darwin Global Management, Ltd. | 0 | $0 | 0.00% | −997,196−100.0% | Sold out |
| Vivo Capital, LLC | 0 | $0 | 0.00% | −956,670−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −884,374−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −766,520−100.0% | Sold out |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −759,565−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −672,890−100.0% | Sold out |
| Glazer Capital, LLC | 0 | $0 | 0.00% | −650,191−100.0% | Sold out |
| Pentwater Capital Management LP | 0 | $0 | 0.00% | −565,000−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −542,722−100.0% | Sold out |
| Beryl Capital Management LLC | 0 | $0 | 0.00% | −522,138−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −520,591−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −509,647−100.0% | Sold out |
| Summit Partners Public Asset Management, LLC | 0 | $0 | 0.00% | −477,527−100.0% | Sold out |
| Maverick Capital LtdSuperinvestorMaverick Capital | 0 | $0 | 0.00% | −455,978−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −382,800−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −377,718−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −358,432−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −348,421−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −310,000−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −293,586−100.0% | Sold out |
| Highland Capital Management Fund Advisors, L.P. | 0 | $0 | 0.00% | −279,900−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −276,551−100.0% | Sold out |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 0 | $0 | 0.00% | −275,000−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −274,962−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −273,243−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −269,389−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −263,332−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −232,537−100.0% | Sold out |
| Spruce Street Capital LP | 0 | $0 | 0.00% | −232,269−100.0% | Sold out |
| Weiss Asset Management LP | 0 | $0 | 0.00% | −224,998−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −222,763−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −216,998−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −212,028−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −210,329−100.0% | Sold out |
| Alpine Associates Management Inc. | 0 | $0 | 0.00% | −208,560−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −207,844−100.0% | Sold out |
| Vivaldi Asset Management, LLC | 0 | $0 | 0.00% | −205,233−100.0% | Sold out |
| Rock Springs Capital Management LP | 0 | $0 | 0.00% | −204,878−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −190,700−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −184,873−100.0% | Sold out |
| Sofinnova Investments, Inc. | 0 | $0 | 0.00% | −180,265−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −179,081−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −165,131−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −164,575−100.0% | Sold out |
| CNH Partners LLC | 0 | $0 | 0.00% | −157,709−100.0% | Sold out |
| Davidson Kempner Capital Management LP | 0 | $0 | 0.00% | −155,631−100.0% | Sold out |
| Water Island Capital LLC | 0 | $0 | 0.00% | −150,708−100.0% | Sold out |
| Gabelli Funds LLC | 0 | $0 | 0.00% | −148,666−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −145,533−100.0% | Sold out |
| Oddo BHF Asset Management SAS | 0 | $0 | 0.00% | −142,500−100.0% | Sold out |
| Whitebox Advisors LLC | 0 | $0 | 0.00% | −125,001−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −116,713−100.0% | Sold out |
| Highbridge Capital Management LLC | 0 | $0 | 0.00% | −112,980−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −110,560−100.0% | Sold out |
| Velan Capital Investment Management LP | 0 | $0 | 0.00% | −108,404−100.0% | Sold out |
| Octagon Capital Advisors LP | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Eversept Partners, LP | 0 | $0 | 0.00% | −98,721−100.0% | Sold out |
| Gabelli & Co Investment Advisers, Inc. | 0 | $0 | 0.00% | −95,805−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −91,000−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −89,145−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −86,869−100.0% | Sold out |
| Superstring Capital Management LP | 0 | $0 | 0.00% | −85,098−100.0% | Sold out |
| Sand Grove Capital Management LLP | 0 | $0 | 0.00% | −80,821−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −79,587−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −78,322−100.0% | Sold out |
| Nan Fung Trinity (HK) Ltd | 0 | $0 | 0.00% | −77,100−100.0% | Sold out |
| Slotnik Capital, LLC | 0 | $0 | 0.00% | −76,245−100.0% | Sold out |
| Picton Mahoney Asset Management | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| Versor Investments LP | 0 | $0 | 0.00% | −73,200−100.0% | Sold out |
| Artia Global Partners LP | 0 | $0 | 0.00% | −70,824−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −68,986−100.0% | Sold out |
| Caxton Associates LLP | 0 | $0 | 0.00% | −68,821−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −67,500−100.0% | Sold out |
| AlphaCore Capital LLC | 0 | $0 | 0.00% | −66,790−100.0% | Sold out |
| Governors Lane LP | 0 | $0 | 0.00% | −62,325−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −59,677−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −59,551−100.0% | Sold out |
| Public Sector Pension Investment Board | 0 | $0 | 0.00% | −58,844−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −58,553−100.0% | Sold out |
| Sagefield Capital LP | 0 | $0 | 0.00% | −57,075−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −56,375−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −56,014−100.0% | Sold out |
| Boxer Capital Management, LLC | 0 | $0 | 0.00% | −53,000−100.0% | Sold out |
| Harvest Management LLC | 0 | $0 | 0.00% | −52,500−100.0% | Sold out |
| Burkehill Global Management, LP | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 0 | $0 | 0.00% | −49,495−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −44,307−100.0% | Sold out |
| Nuveen, LLC | 0 | $0 | 0.00% | −43,127−100.0% | Sold out |
| Birnam Oak Advisors, LP | 0 | $0 | 0.00% | −41,414−100.0% | Sold out |
| Athos Capital Ltd | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −38,811−100.0% | Sold out |
| Resolute Capital Asset Partners LLC | 0 | $0 | 0.00% | −37,315−100.0% | Sold out |
| Chicago Capital Management, LLC | 0 | $0 | 0.00% | −49,000−100.0% | Sold out |
| Abc Arbitrage SA | 0 | $0 | 0.00% | −29,894−100.0% | Sold out |